On 2026-03-26, SpyGlass Pharma, Inc. (SGP) announced earnings per share of -5.72 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of -6.61.

The next expected annoucement date for quarterly earnings is 2026-06-25, with an average estimated earnings per share of -0.67 for the fiscal quarter ending 2026-03-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.